trial

Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?

NCTId NCT01312272
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 24 (actual)
Sponsored by VA Greater Los Angeles Healthcare System
Primary completion 2012-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
24 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2011-04
Primary completion
2012-08
Eligibility
MALE · 18 Years · 55 Years

Interventions & indications

Drugs
Oxytocin

Sponsors

VA Greater Los Angeles Healthcare SystemLead Sponsor

Investigators

1
Stephen J Heishman, Ph.D.Principal Investigator

Sites

1 total
Los Angeles, United States

Facts & assertions

4 sourced
Enrollment
24
Phase
NA
Primary Completion Date
2012-08
Status
COMPLETED
relationships
The graph out of here
drug
Oxytocin
drug
lead_sponsor
VA Greater Los Angeles Healthcare System
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Stephen J Heishman, Ph.D.
person